Do you have a primary diagnosis of idiopathic hypersomnia (IH)?
“Join Us in the Fight Against Idiopathic Hypersomnia: Your Participation Can Help Advance Research and Improve Lives”
“Join Us in the Fight Against Idiopathic Hypersomnia: Your Participation Can Help Advance Research and Improve Lives”
Idiopathic hypersomnia is a neurological disorder which is characterized primarily by excessive sleep and excessive daytime sleepiness
Awareness and diagnosis of IH has increased markedly over the last several years. However, IH patients are severely limited in effective treatment options
The study will last at least 14 weeks, but may be extended to up to 10 months. During this study, you will receive active study drug for most visits except for a two-week period when half of the study subjects will receive active drug and half will receive placebo. The purpose of this research study is to understand how well the study drug works to reduce excessive daytime sleepiness in idiopathic hypersomnia. This study will also evaluate the safety of the study drug.
Our team will contact you to verify your eligiblity and answer any questions you may have.